IDEAYA Biosciences, Inc. Other Current Liabilities
IDEAYA Biosciences, Inc. (IDYA) had Other Current Liabilities of $3.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2022-03-18
- 2021-06-30: Other Liabilities, Current $3.00K.
- 2021-03-31: Other Liabilities, Current $6.00K.
- 2020-12-31: Other Liabilities, Current $18.00K.
- 2020-09-30: Other Liabilities, Current $29.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2021-06-30 | $3.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $6.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $18.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $29.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $45.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $57.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $63.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $76.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $89.00K 10-Q · filed 2019-08-12 |
| 2018-12-31 | $114.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |